Waverley Pharma Inc V.WAVE

Healthcare Biotechnology

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.

TSXV:WAVE - Post by User

Waverley Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by flight100on Oct 14, 2020 11:27am

140 Views

Post# 31713934

WAVE seems ready for another upward move

As indicated last month when WAVE hit 0.25, it is a good stock to buy under 0.14 and then sell at 0.23+. The stock has been doing 3-4 times over the last 2-3 months. I bought back at 0.125 yesterday and will wait for 0.20s exit that could happen any day now . The stock price moves very fast.

<< Previous

Bullboard Posts

Next >>

Hillcrest and Ocean Batteries expand marine electrification collaboration